Imperial College London

Professor David MacIntyre

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Professor in Reproduction Systems Medicine
 
 
 
//

Contact

 

+44 (0)20 7594 2195d.macintyre Website

 
 
//

Location

 

Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Whelan:2022:10.3390/cancers14112708,
author = {Whelan, E and Kalliala, I and Semertzidou, A and Raglan, O and Bowden, S and Kechagias, K and Markozannes, G and Cividini, S and McNeish, I and Marchesi, J and MacIntyre, D and Bennett, P and Tsilidis, K and Kyrgiou, M},
doi = {10.3390/cancers14112708},
journal = {Cancers},
pages = {2708--2708},
title = {Risk Factors for Ovarian Cancer: An Umbrella Review of the Literature},
url = {http://dx.doi.org/10.3390/cancers14112708},
volume = {14},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - <jats:p>Several non-genetic factors have been associated with ovarian cancer incidence or mortality. To evaluate the strength and validity of the evidence we conducted an umbrella review of the literature that included systematic reviews/meta-analyses that evaluated the link between non-genetic risk factors and ovarian cancer incidence and mortality. We searched PubMed, EMBASE, Cochrane Database of Systematic Reviews and performed a manual screening of references. Evidence was graded into strong, highly suggestive, suggestive or weak based on statistical significance of the random effects summary estimate and the largest study in a meta-analysis, the number of cases, between-study heterogeneity, 95% prediction intervals, small study effects, and presence of excess significance bias. We identified 212 meta-analyses, investigating 55 non-genetic risk factors for ovarian cancer. Risk factors were grouped in eight broad categories: anthropometric indices, dietary intake, physical activity, pre-existing medical conditions, past drug history, biochemical markers, past gynaecological history and smoking. Of the 174 meta-analyses of cohort studies assessing 44 factors, six associations were graded with strong evidence. Greater height (RR per 10 cm 1.16, 95% confidence interval (CI) 1.11–1.20), body mass index (BMI) (RR ≥ 30 kg/m2 versus normal 1.27, 95% CI 1.17–1.38) and three exposures of varying preparations and usage related to hormone replacement therapy (HRT) use increased the risk of developing ovarian cancer. Use of oral contraceptive pill reduced the risk (RR 0.74, 95% CI 0.69–0.80). Refining the significance of genuine risk factors for the development of ovarian cancer may potentially increase awareness in women at risk, aid prevention and early detection.</jats:p>
AU - Whelan,E
AU - Kalliala,I
AU - Semertzidou,A
AU - Raglan,O
AU - Bowden,S
AU - Kechagias,K
AU - Markozannes,G
AU - Cividini,S
AU - McNeish,I
AU - Marchesi,J
AU - MacIntyre,D
AU - Bennett,P
AU - Tsilidis,K
AU - Kyrgiou,M
DO - 10.3390/cancers14112708
EP - 2708
PY - 2022///
SP - 2708
TI - Risk Factors for Ovarian Cancer: An Umbrella Review of the Literature
T2 - Cancers
UR - http://dx.doi.org/10.3390/cancers14112708
UR - http://hdl.handle.net/10044/1/98840
VL - 14
ER -